Christoph U Correll Selected Research

Injections

2/2024	Relapse Rates With Paliperidone Palmitate in Adult Patients With Schizophrenia: Results for the 6-Month Formulation From an Open-label Extension Study Compared to Real-World Data for the 1-Month and 3-Month Formulations.
12/2023	Efficacy and safety of TV-46000, a long-acting, subcutaneous, injectable formulation of risperidone, for schizophrenia: a randomised clinical trial in the USA and Bulgaria.
9/2023	Switching to long-acting injectable antipsychotics: pharmacological considerations and practical approaches.
3/2023	Delphi panel to obtain clinical consensus about using long-acting injectable antipsychotics to treat first-episode and early-phase schizophrenia: Treatment goals and approaches to functional recovery.
2/2023	Comparison of clinical outcomes in patients with schizophrenia following different long-acting injectable event-driven initiation strategies.
1/2023	Comparative effectiveness study of paliperidone palmitate 6-month with a real-world external comparator arm of paliperidone palmitate 1-month or 3-month in patients with schizophrenia.
1/2023	Personal and Social Functioning and Health-Related Quality of Life in Patients with Schizophrenia Treated with the Long-Acting Injectable Antipsychotic Risperidone ISM.
1/2023	Effect of the GLP-1 receptor agonist semaglutide on metabolic disturbances in clozapine-treated or olanzapine-treated patients with a schizophrenia spectrum disorder: study protocol of a placebo-controlled, randomised clinical trial (SemaPsychiatry).
1/2023	Oral and long-acting injectable antipsychotic discontinuation and relationship to side effects in people with first episode psychosis: a longitudinal analysis of electronic health record data.
1/2023	Delphi panel to obtain clinical consensus about using long-acting injectable antipsychotics to treat first-episode and early-phase schizophrenia: treatment goals and approaches to functional recovery.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christoph U Correll Research Topics

Disease

256	Schizophrenia (Dementia Praecox) 05/2024 - 11/2003
78	Psychotic Disorders (Schizoaffective Disorder) 05/2024 - 04/2007
74	Weight Gain 11/2023 - 08/2004
44	Bipolar Disorder (Manic Depressive Psychosis) 01/2024 - 01/2007
37	Mental Disorders (Mental Disorder) 04/2024 - 06/2005
27	Treatment-Resistant Schizophrenia 04/2024 - 08/2011
23	Body Weight (Weight, Body) 01/2023 - 01/2011
22	Tardive Dyskinesia 05/2024 - 03/2004
21	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2023 - 06/2005
20	Obesity 11/2023 - 08/2004
17	Insulin Resistance 01/2023 - 01/2007
16	Anorexia Nervosa 12/2023 - 06/2012
15	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 03/2024 - 10/2009
15	Substance-Related Disorders (Drug Abuse) 03/2024 - 01/2009
15	Psychomotor Agitation (Akathisia) 11/2023 - 07/2010
13	Type 2 Diabetes Mellitus (MODY) 01/2023 - 08/2010
12	Dyskinesias (Dyskinesia) 05/2024 - 03/2004
11	Hyperprolactinemia 01/2023 - 01/2004
11	Hypertension (High Blood Pressure) 01/2023 - 11/2008
11	Dyslipidemias (Dyslipidemia) 01/2023 - 11/2008
11	Mania (Manias) 01/2022 - 03/2010
9	Major Depressive Disorder (Major Depressive Disorders) 11/2023 - 08/2011
9	Sleepiness 01/2023 - 04/2012
9	Mood Disorders (Mood Disorder) 01/2023 - 03/2013
9	Weight Loss (Weight Reduction) 01/2021 - 06/2007
8	Neurobehavioral Manifestations 01/2023 - 01/2011
8	Parkinsonian Disorders (Parkinsonism) 12/2022 - 09/2015
7	Dementia (Dementias) 01/2023 - 10/2012
7	Agranulocytosis (Granulocytopenia) 03/2022 - 02/2012
7	Neuroleptic Malignant Syndrome 10/2021 - 02/2012
7	Overweight 02/2020 - 09/2010
6	Neoplasms (Cancer) 04/2024 - 11/2015
6	Myocarditis (Carditis) 11/2023 - 02/2012
6	Coronary Disease (Coronary Heart Disease) 01/2023 - 04/2006
6	Depressive Disorder (Melancholia) 10/2022 - 04/2015
6	COVID-19 10/2022 - 01/2020
6	Cognitive Dysfunction 03/2021 - 07/2012
6	Prediabetic State (Prediabetes) 11/2020 - 04/2012
6	Autism Spectrum Disorder 12/2019 - 10/2013
5	Inflammation (Inflammations) 03/2024 - 01/2020
5	Hyperglycemia 01/2023 - 11/2008
5	Autistic Disorder (Autism) 01/2022 - 10/2009
5	Alcoholism (Alcohol Abuse) 01/2021 - 11/2010
5	Sleep Initiation and Maintenance Disorders (Insomnia) 06/2020 - 10/2011
5	Diabetes Mellitus 06/2015 - 05/2009
4	Breast Neoplasms (Breast Cancer) 04/2024 - 01/2020
4	Drug-Related Side Effects and Adverse Reactions 12/2023 - 01/2020
4	Intellectual Disability (Idiocy) 11/2023 - 01/2016
4	Pain (Aches) 01/2023 - 01/2017
4	Nausea 01/2023 - 05/2016

Drug/Important Bio-Agent (IBA)

298	Antipsychotic Agents (Antipsychotics)IBA 05/2024 - 11/2003
68	Clozapine (Clozaril)FDA LinkGeneric 04/2024 - 01/2007
47	Olanzapine (Zyprexa)FDA Link 05/2024 - 03/2008
43	Aripiprazole (Abilify)FDA Link 11/2023 - 01/2007
31	Risperidone (Risperdal Consta)FDA LinkGeneric 05/2024 - 01/2004
30	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 06/2005
29	Quetiapine Fumarate (Seroquel)FDA Link 05/2024 - 01/2007
26	ProlactinIBA 04/2024 - 01/2004
23	Antidepressive Agents (Antidepressants)IBA 12/2023 - 04/2007
20	LipidsIBA 01/2023 - 01/2007
15	Insulin (Novolin)FDA Link 01/2023 - 10/2010
12	Polytetrafluoroethylene (Teflon)FDA Link 03/2024 - 01/2016
12	Triglycerides (Triacylglycerol)IBA 01/2023 - 01/2007
11	Dopamine (Intropin)FDA LinkGeneric 01/2023 - 01/2016
11	HDL CholesterolIBA 09/2017 - 04/2006
10	ziprasidone (Geodon)FDA Link 05/2024 - 01/2007
10	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2010
10	CholesterolIBA 01/2023 - 04/2006
10	Lurasidone Hydrochloride FDA Link 01/2023 - 09/2012
9	Paliperidone Palmitate FDA Link 02/2024 - 09/2012
9	Cholinergic Antagonists (Anticholinergics)IBA 12/2022 - 07/2010
9	BenzodiazepinesIBA 12/2022 - 07/2010
9	Metformin (Glucophage)FDA LinkGeneric 11/2020 - 06/2010
8	valbenazineIBA 05/2024 - 01/2016
8	Serotonin (5 Hydroxytryptamine)IBA 01/2023 - 01/2012
7	Dopamine Receptors (Dopamine Receptor)IBA 12/2023 - 10/2007
7	brexpiprazoleIBA 01/2023 - 09/2015
7	LDL CholesterolIBA 10/2022 - 04/2008
7	TeaIBA 01/2022 - 07/2014
7	Hemoglobins (Hemoglobin)IBA 01/2021 - 10/2012
6	3-carboxamido-4-hydroxynaltrexoneIBA 01/2023 - 01/2018
6	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2023 - 10/2018
5	mesoglycanIBA 02/2024 - 01/2020
5	cariprazineIBA 01/2023 - 01/2019
5	AntioxidantsIBA 10/2022 - 11/2015
5	C-Reactive ProteinIBA 03/2022 - 01/2012
5	LithiumIBA 10/2021 - 10/2016
5	Glutamic Acid (Glutamate)FDA Link 01/2020 - 05/2015
5	HDL LipoproteinsIBA 08/2019 - 04/2006
5	Liraglutide FDA Link 01/2019 - 03/2014
4	Amisulpride (Solian)IBA 09/2023 - 10/2014
4	Narcotic Antagonists (Opioid Antagonists)IBA 08/2023 - 01/2019

Therapy/Procedure

44	Injections 02/2024 - 10/2013
24	Therapeutics 10/2023 - 10/2009
19	Secondary Prevention 02/2024 - 01/2011
17	Polypharmacy 01/2020 - 01/2007
5	Drug Therapy (Chemotherapy) 02/2023 - 11/2010
5	Duration of Therapy 02/2022 - 08/2012
4	Length of Stay 12/2023 - 06/2014
4	Combined Modality Therapy 12/2023 - 03/2015